American journal of obstetrics and gynecology · 2004
National Institute on Drug Abuse Conference report on placental proteins, drug transport, and fetal development.
Consensus StatementConsensus Development Conference, NIHСтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Thadani Pushpa V, Strauss Jerome F, Dey Sudhansu K, Anderson Virginia M, Audus Kenneth L, Coats Karen S, Cross James C, Erlebacher Adrian, Ganapathy Vadivel, Linzer Daniel I, Miller Richard K, Novak Donald A, Rapaka Rao S, Sadovsky Yoel, Salafia Carolyn M, Soares Michael, Unadkat Jashvant
Аннотация
The use of illicit and licit drugs during pregnancy is a major public health concern because of potential adverse effects on the fetus and the risk to maternal health. Because the placenta is the primary link between the mother and the conceptus and is essential for the growth and survival of the fetus, abnormalities in placental formation and function resulting from drug use could have a major influence on pregnancy outcome. At present, little information is available on the impact of abused drugs on placental biology alone or in combination with other "host" factors (eg, stress, infections). This prompted the National Institute on Drug Abuse (NIDA) to convene a meeting of experts in placental biology to review cutting-edge research with the mission to translate existing information to new clinical and research initiatives in the drug abuse field. This report summarizes the presentations and research recommendations resulting from the workshop discussions.